基因疗法在临床开发中用于治疗视网膜疾病
Michelle E McClements1,2, Maram E A Abdalla Elsayed3,4,5, Lauren Major3,4
1Nuffield Laboratory of Ophthalmology, Department of Clinical Neurosciences, University of Oxford, Wellington Square, Oxford, OX1 2JD, UK. maclaren@eye.ox.ac.uk.
Molecular diagnosis & therapy
|July 2, 2024
概括
基因疗法为遗传性视网膜疾病提供了希望,许多人显示出安全的分娩和改善的视力. 目前正在进行的试验完善了方法,尽管有一些挫折,指导了治疗眼睛疾病的未来进展.
科学领域:
- 眼科医生 眼科 眼科
- 遗传学 遗传学 是一个
- 生物技术是生物技术.
背景情况:
- 基因疗法正在成为遗传性视网膜疾病的有希望的治疗方法.
- 几种基因疗法在临床试验中取得了成功,改善了视觉敏度和视网膜功能.
- 尽管取得了进展,但报告的试验数据存在差距,一些有希望的选择缺乏同行评审.
研究的目的:
- 审查最近和正在进行的视网膜基因疗法治疗的临床试验.
- 讨论这些试验的积极和消极方面,包括治疗潜力和风险.
- 分析试验结果如何指导未来的研究和患者监测.
主要方法:
- 对针对视网膜疾病的基因疗法的当前和最近的临床试验数据的审查.
- 从人类临床试验中对安全性,疗效和主要终点结果的分析.
- 讨论数据可访问性,包括同行评审出版物与新闻稿.
主要成果:
- 许多基因疗法已在人类试验中安全地用于遗传性视网膜疾病.
- 虽然许多试验显示出积极的安全结果和改善视力,但有些试验未能达到主要终点.
- 从试验成功和失败中吸取的经验教训对于优化未来临床研究至关重要.
结论:
- 基因疗法具有显著的潜力,可以彻底改变视网膜疾病的治疗,提供新的视力.
- 持续的研究和严格的测试对于通过监管批准推进这些疗法至关重要.
- 了解潜在的益处和风险对于成功开发用于眼部疾病的基因疗法至关重要.
相关概念视频
00:59Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
01:22iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K